| Fiscal Year End | Company Status | Exempt Flag |
| March 31 | Trading | N |
|
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 31/Jul/2007 | | Canada | British Columbia | |
|
|
| Exchange Filing Office |
| Location |
| Vancouver Regional Service Office |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| Research And Development In The Life Sciences
| News Release January 20, 2015-T-Bird Pharma Inc. is the parent company of Thunderbird Biomedical Inc., a wholly owned private subsidiary formed in January, 2013. The principal activities of Thunderbird are the production of marijuana from its Victoria, British Columbia production facility, as regulated by the Marihuana for Medical Purposes Regulations (Canada). Thunderbird obtained a medical marijuana license to undertake the production of medical marijuana in February 2014, being the fifth company in Canada to obtain such a license. Thunderbird was acquired by T-Bird in September, 2013.
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| TPI | T-Bird Pharma Inc. | TSX Venture | TRADING |
|
|
| Name History | From | To |
| T-Bird Pharma Inc. | 9/Sep/2014 | Present |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Fall 2014 CFR | Not Received |
|
|
|
|
|
